Skip to main content
Log in

Auf Warnzeichen achten

Erysipel: Wann wird es kritisch?

Erysipelas

  • FORTBILDUNG . SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Das Erysipel ist eine klassische Blickdiagnose. Bei welchen Symptomen müssen Sie eine weiterführende Diagnostik veranlassen? Welche Antibiotika sind zu Beginn, welche bei kompliziertem Verlauf empfehlenswert?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Kilburn SA, Featherstone P, Higgins B, Brindle R. Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev 2010:CD004299.

  2. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59:e10–52.

    Article  PubMed  Google Scholar 

  3. Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA 2016;316:325–37.

    Article  PubMed  Google Scholar 

  4. Dalal A, Eskin-Schwartz M, Mimouni D, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev 2017;6:CD009758.

    PubMed  Google Scholar 

  5. Ferreira A, Bolland MJ, Thomas MG. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas. Infection 2016;44:607–15.

    Article  CAS  PubMed  Google Scholar 

  6. Bodmann K-F, Grabein B, Kresken M, et al. S2k Leitlinie: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen —Update 2018. Paul-Ehrlich-Gesellschaft, verfügbar unter http://wwwawmforg/uploads/tx_szleitlinien/S82-006l_S2k_Parenterale_Antibiotika_2018-1pdf, 2018.

  7. Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J. A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection. Clin Infect Dis 2016;62:545–51.

    Article  CAS  PubMed  Google Scholar 

  8. Bergkvist PI, Sjobeck K. Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. Scand J Infect Dis 1997;29:377–82.

    Article  CAS  PubMed  Google Scholar 

  9. Dall L, Peterson S, Simmons T, Dall A. Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy. Cutis 2005;75:177–80.

    PubMed  Google Scholar 

  10. Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas—risk factors and clinical presentation. BMC Infect Dis 2014;14:270.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich Seybold MSc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seybold, U., Stubbe, H., Draenert, R. et al. Erysipel: Wann wird es kritisch?. MMW - Fortschritte der Medizin 160, 37–40 (2018). https://doi.org/10.1007/s15006-018-0580-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-018-0580-3

Keywords

Navigation